Boots Sir Nigel Rudd has been appointed as a non-executive director of the Boots Co Plc. Sir Nigel is chairman of Williams Plc and non-executive chairman of Pilkington Plc and Pendragon Plc.
Glaxo Smithkline Glaxo Wellcome Plc and Smithkline Beecham Plc have announced further details of the executive management team which will run the merged Glaxo Smithkline Plc: senior vice-president and corporate counsel, Mr James Beery; presidents of the United States pharmaceutical subsidiaries, Mr George Morrow and Mr David Stout; senior vice-president for clinical development, Mr James Palmer; senior vice-president for human resources, Mr Daniel Phelan; president for international pharmaceuticals, Mr Howard Pein; president for worldwide manufacturing and supply operations, Mr Timothy Tyson; president for European pharmaceuticals, Mr Chris Viehbacher; president for consumer health care, Mr John Ziegler; senior vice-president for discovery research, Mr Peter Goodfellow; senior vice-president for preclinical development, Mr Robert Lynn; senior vice-president for genetics research, Mr Allen Roses.
Medac Medac UK Ltd has appointed Mr David Maybury as hospital business development manager with effect from April 3. Mr Maybury previously worked in sales and marketing at Faulding Pharmaceuticals Ltd. He will report to Mr Alastair McMurray, MRPharmS, managing director of Medac, formerly principal oncology pharmacist at the Beatson oncology centre, Glasgow.